Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors

Vaccination for SARS-CoV-2 provides significant protection against the infection in the general population. However, only limited data exist for patients with cancer under systemic therapy. Based on this, our site has initiated a study evaluating safety and efficacy of SARS-CoV-2 vaccination in pati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Terpos, Evangelos, Zagouri, Flora, Liontos, Michalis, Sklirou, Aimilia D., Koutsoukos, Konstantinos, Markellos, Christos, Briasoulis, Alexandros, Papanagnou, Eleni-Dimitra, Trougakos, Ioannis P., Dimopoulos, Meletios-Athanasios
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Letter to the Editor
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165511/
https://ncbi.nlm.nih.gov/pubmed/34059088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-021-01099-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados